Cargando…
Remdesivir for COVID-19 in Europe: will it provide value for money?
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836228/ https://www.ncbi.nlm.nih.gov/pubmed/33341157 http://dx.doi.org/10.1016/S2213-2600(20)30568-3 |
| _version_ | 1783642702842167296 |
|---|---|
| author | Dal-Ré, Rafael Banzi, Rita Georgin-Lavialle, Sophie Porcher, Raphaël Sofat, Reecha Zeitlinger, Markus Rosendaal, Frits R |
| author_facet | Dal-Ré, Rafael Banzi, Rita Georgin-Lavialle, Sophie Porcher, Raphaël Sofat, Reecha Zeitlinger, Markus Rosendaal, Frits R |
| author_sort | Dal-Ré, Rafael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7836228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78362282021-01-26 Remdesivir for COVID-19 in Europe: will it provide value for money? Dal-Ré, Rafael Banzi, Rita Georgin-Lavialle, Sophie Porcher, Raphaël Sofat, Reecha Zeitlinger, Markus Rosendaal, Frits R Lancet Respir Med Comment Elsevier Ltd. 2021-02 2020-12-17 /pmc/articles/PMC7836228/ /pubmed/33341157 http://dx.doi.org/10.1016/S2213-2600(20)30568-3 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Dal-Ré, Rafael Banzi, Rita Georgin-Lavialle, Sophie Porcher, Raphaël Sofat, Reecha Zeitlinger, Markus Rosendaal, Frits R Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title | Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title_full | Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title_fullStr | Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title_full_unstemmed | Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title_short | Remdesivir for COVID-19 in Europe: will it provide value for money? |
| title_sort | remdesivir for covid-19 in europe: will it provide value for money? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836228/ https://www.ncbi.nlm.nih.gov/pubmed/33341157 http://dx.doi.org/10.1016/S2213-2600(20)30568-3 |
| work_keys_str_mv | AT dalrerafael remdesivirforcovid19ineuropewillitprovidevalueformoney AT banzirita remdesivirforcovid19ineuropewillitprovidevalueformoney AT georginlaviallesophie remdesivirforcovid19ineuropewillitprovidevalueformoney AT porcherraphael remdesivirforcovid19ineuropewillitprovidevalueformoney AT sofatreecha remdesivirforcovid19ineuropewillitprovidevalueformoney AT zeitlingermarkus remdesivirforcovid19ineuropewillitprovidevalueformoney AT rosendaalfritsr remdesivirforcovid19ineuropewillitprovidevalueformoney |